Condition: Cardiac Arrest · Extracorporeal Membrane Oxygenation · Reperfusion Injury · Sponsor: Boston Children's Hospital
The purpose of this project is to test the feasibility and safety of inhaled hydrogen gas (H2) administration as a rescue therapy during cardiac arrest requiring extracorporeal cardiopulmonary resuscitation (ECPR, i.e. mechanical circulatory support). Under exemption from informed consent, patients undergoing refractory cardiac arrest in the cardiac ICU at a participating center will be randomized to standard therapy with or without the administration of 2% hydrogen in gases administered via the ventilator and ECMO membrane for 72 hours.
This description comes directly from the study's public registry record.
John N Kheir, MD · 8576368890 · john.kheir@childrens.harvard.edu
Victoria Habet, DO
Always discuss trial participation with your own doctor first.
| Children's National Hospital | Washington D.C., District of Columbia, United States | Not Yet Recruiting |
| Boston Children's Hospital | Boston, Massachusetts, United States | Recruiting |
| Children's Mercy Kansas City | Kansas City, Missouri, United States | Not Yet Recruiting |
| Primary Children's Hospital | Salt Lake City, Utah, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05574296